2026 Q2 Portfolio Activity
In 2026 Q2, PERCEPTIVE ADVISORS LLC maintained a portfolio of 123 distinct positions. The most significant new addition was BIOGEN INC, now representing 0.90% of the total fund value. They heavily accumulated shares in ASCENDIS PHARMA A/S, increasing the position by 46.8%. Conversely, PERCEPTIVE ADVISORS LLC completely exited their position in ASCENDIS PHARMA A/S.
Position History
hover any row below to update
Loading…
Total Positions
123
Quarter
2026 Q2
Top Holding
PRAX (10.2%)
Top 10 Concentration
47.3%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 123
PERCEPTIVE ADVISORS LLC Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 10.23% | 12.83% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
2,035,986 | $681,627,753 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SYRE
SPYRE THERAPEUT...
|
Healthcare | 5.76% | 3.73% |
#2
5
Prev: #7
|
5.8 |
—
|
536,271 | 14.2% |
P
S
|
4,319,496 | $383,484,855 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CELC
CELCUITY INC
|
Healthcare | 5.02% | 6.98% |
#3
1
Prev: #2
|
3.5 |
—
|
70,000 | 2.2% |
P
S
|
3,197,200 | $334,491,064 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
ASCENDIS PHARMA...
|
|
Unknown | 4.66% | — |
#4
Prev: #—
|
5.9 |
—
|
1,163,721 | — |
NEW
|
1,163,721 | $310,387,665 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 4.31% | 4.04% |
#5
1
Prev: #6
|
4.2 |
—
|
212,500 | 9.0% |
P
S
|
2,586,295 | $287,156,334 | 2017 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ROIV
ROIVANT SCIENCE...
|
Healthcare | 4.30% | 4.49% |
#6
2
Prev: #4
|
2.2 |
—
|
-200,000 | -2.4% |
P
S
|
8,085,461 | $286,144,465 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RLAY
RELAY THERAPEUT...
|
Healthcare | 3.96% | 1.90% |
#7
8
Prev: #15
|
4.1 |
—
|
4,355,046 | 44.7% |
P
S
|
14,106,187 | $263,926,759 | 2020 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TVTX
TRAVERE THERAPE...
|
Healthcare | 3.20% | 2.41% |
#8
4
Prev: #12
|
1.8 |
—
|
-389,977 | -9.4% |
P
S
|
3,752,574 | $213,183,729 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
KARDIGAN INC
|
|
Unknown | 2.94% | — |
#9
Prev: #—
|
4.7 |
—
|
8,200,662 | — |
NEW
|
8,200,662 | $195,585,788 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
NUVL
NUVALENT INC
|
Healthcare | 2.93% | 3.17% |
#10
2
Prev: #8
|
2.2 |
—
|
no change | no change |
P
S
|
1,580,505 | $195,192,368 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 2.67% | 2.73% |
#11
2
Prev: #9
|
1.6 |
—
|
-50,000 | -1.1% |
P
S
|
4,373,974 | $177,714,564 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
APGE
APOGEE THERAPEU...
|
Healthcare | 2.61% | 2.54% |
#12
1
Prev: #11
|
1.5 |
—
|
-232,271 | -15.1% |
P
S
|
1,308,113 | $173,625,838 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AMLX
AMYLYX PHARMACE...
|
Healthcare | 2.25% | 2.25% |
#13
Prev: #13
|
1.4 |
—
|
50,000 | 0.6% |
P
S
|
8,334,882 | $149,694,481 | 2022 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MGTX
MEIRAGTX HLDGS ...
|
Healthcare | 2.19% | 1.75% |
#14
3
Prev: #17
|
1.4 |
—
|
460,555 | 4.5% |
P
S
|
10,786,658 | $145,727,749 | 2018 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ORKA
ORUKA THERAPEUT...
|
Healthcare | 1.92% | 1.34% |
#15
7
Prev: #22
|
1.3 |
—
|
-50,438 | -3.6% |
P
S
|
1,345,063 | $128,009,646 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
INBX
INHIBRX BIOSCIE...
|
Healthcare | 1.85% | 1.90% |
#16
Prev: #16
|
1.2 |
—
|
-144,944 | -10.0% |
P
S
|
1,297,763 | $122,963,044 | 2021 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PTGX
PROTAGONIST THE...
|
Healthcare | 1.81% | 2.54% |
#17
7
Prev: #10
|
0.7 |
—
|
-249,000 | -20.2% |
P
S
|
981,879 | $120,358,728 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SLDB
SOLID BIOSCIENC...
|
Healthcare | 1.79% | 1.68% |
#18
1
Prev: #19
|
1.7 |
—
|
no change | no change |
P
S
|
11,906,646 | $118,947,393 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ZYME
ZYMEWORKS INC
|
Healthcare | 1.64% | 1.72% |
#19
1
Prev: #18
|
2.7 |
—
|
672,875 | 19.2% |
P
S
|
4,182,953 | $109,342,391 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TNGX
TANGO THERAPEUT...
|
Healthcare | 1.58% | 0.33% |
#20
37
Prev: #57
|
3.6 |
—
|
2,568,847 | 317.9% |
P
S
|
3,377,000 | $105,565,020 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IMTX
IMMATICS N.V
|
Healthcare | 1.58% | 2.00% |
#21
7
Prev: #14
|
1.6 |
—
|
no change | no change |
P
S
|
10,383,456 | $105,184,409 | 2020 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NRIX
NURIX THERAPEUT...
|
Healthcare | 1.57% | 1.13% |
#22
2
Prev: #24
|
2.6 |
—
|
609,545 | 16.4% |
P
S
|
4,320,422 | $104,813,438 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BCRX
BIOCRYST PHARMA...
|
Healthcare | 1.55% | 1.38% |
#23
2
Prev: #21
|
3.1 |
—
|
2,874,855 | 38.7% |
P
S
|
10,308,888 | $103,088,880 | 2002 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 1.48% | 0.49% |
#24
21
Prev: #45
|
3.6 |
—
|
269,000 | 104.0% |
P
S
|
527,600 | $98,808,928 | 2020 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
AVALYN PHARMACE...
|
|
Unknown | 1.32% | — |
#25
Prev: #—
|
4.0 |
—
|
2,675,296 | — |
NEW
|
2,675,296 | $88,070,744 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
MRNA
PUT
MODERNA INC
|
PUT Option | 1.05% | 0.99% |
#26
1
Prev: #25
|
1.4 |
—
|
no change | no change |
P
S
|
1,000,000 | $70,030,000 | 2020 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 0.90% | 1.66% |
#27
7
Prev: #20
|
0.4 |
—
|
-1,979,604 | -42.4% |
P
S
|
2,689,235 | $59,727,909 | 2020 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BIIB
BIOGEN INC
|
Healthcare | 0.90% | — |
#28
Prev: #—
|
3.9 |
—
|
276,173 | — |
NEW
|
276,173 | $59,669,938 | 2004 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 0.79% | 0.78% |
#29
1
Prev: #30
|
0.8 |
—
|
-240,000 | -15.0% |
P
S
|
1,357,383 | $52,299,967 | 2020 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
UNH
UNITEDHEALTH GR...
|
Healthcare | 0.73% | — |
#30
Prev: #—
|
3.8 |
—
|
116,806 | — |
NEW
|
116,806 | $48,548,078 | 2006 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
XBI
PUT
SPDR SERIES TRU...
|
PUT Option | 0.71% | — |
#31
Prev: #—
|
3.8 |
—
|
300,000 | — |
NEW
|
300,000 | $47,475,000 | 2015 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 0.67% | 0.74% |
#32
Prev: #32
|
2.3 |
—
|
62,000 | 12.3% |
P
S
|
566,000 | $44,878,140 | 2003 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
STRO
SUTRO BIOPHARMA...
|
Healthcare | 0.65% | 0.35% |
#33
23
Prev: #56
|
3.3 |
—
|
589,539 | 82.4% |
P
S
|
1,304,846 | $43,320,887 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ANRO
ALTO NEUROSCIEN...
|
Healthcare | 0.64% | 0.88% |
#34
6
Prev: #28
|
0.8 |
—
|
-400,000 | -19.9% |
P
S
|
1,609,893 | $42,485,076 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
JAZZ
JAZZ PHARMACEUT...
|
Healthcare | 0.61% | 0.63% |
#35
2
Prev: #37
|
1.2 |
—
|
no change | no change |
P
S
|
170,000 | $40,964,900 | 2012 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CRVS
CORVUS PHARMACE...
|
Healthcare | 0.60% | 0.66% |
#36
1
Prev: #35
|
2.2 |
—
|
375,000 | 16.4% |
P
S
|
2,667,441 | $39,851,569 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SION
SIONNA THERAPEU...
|
Healthcare | 0.60% | 0.52% |
#37
6
Prev: #43
|
2.7 |
—
|
246,561 | 37.4% |
P
S
|
905,000 | $39,810,950 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CTMX
CYTOMX THERAPEU...
|
Healthcare | 0.59% | 0.93% |
#38
11
Prev: #27
|
0.7 |
—
|
340,361 | 3.4% |
P
S
|
10,439,185 | $39,146,944 | 2015 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AORT
ARTIVION INC
|
Healthcare | 0.59% | 1.17% |
#39
16
Prev: #23
|
2.2 |
—
|
100,000 | 6.1% |
P
S
|
1,737,290 | $39,036,906 | 2016 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
XFOR
X4 PHARMACEUTIC...
|
Healthcare | 0.56% | 0.54% |
#40
1
Prev: #39
|
2.2 |
—
|
1,195,843 | 17.7% |
P
S
|
7,933,491 | $37,049,403 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CORT
CORCEPT THERAPE...
|
Healthcare | 0.52% | 0.04% |
#41
46
Prev: #87
|
3.2 |
—
|
348,385 | 696.8% |
P
S
|
398,385 | $34,639,576 | 2005 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RGEN
REPLIGEN CORP
|
Healthcare | 0.51% | 0.65% |
#42
6
Prev: #36
|
0.7 |
—
|
-32,329 | -11.5% |
P
S
|
248,212 | $33,866,045 | 2002 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AVR
ANTERIS TECHNOL...
|
Healthcare | 0.51% | 0.37% |
#43
12
Prev: #55
|
1.2 |
—
|
no change | no change |
P
S
|
3,425,476 | $33,740,939 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RAPP
RAPPORT THERAPE...
|
Healthcare | 0.48% | 0.41% |
#44
8
Prev: #52
|
2.2 |
—
|
99,419 | 14.8% |
P
S
|
773,342 | $32,225,161 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GLTO
DAMORA THERAPEU...
|
Healthcare | 0.48% | 0.62% |
#45
7
Prev: #38
|
1.2 |
—
|
no change | no change |
P
S
|
1,223,000 | $31,810,230 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CRL
CHARLES RIV LAB...
|
Healthcare | 0.48% | — |
#46
Prev: #—
|
3.7 |
—
|
140,000 | — |
NEW
|
140,000 | $31,750,600 | 2006 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 0.44% | 0.50% |
#47
3
Prev: #44
|
0.2 |
—
|
-31,500 | -21.0% |
P
S
|
118,450 | $28,993,007 | 2019 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EYPT
PUT
EYEPOINT INC
|
PUT Option | 0.43% | — |
#48
Prev: #—
|
3.7 |
—
|
2,000,000 | — |
NEW
|
2,000,000 | $28,600,000 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DBVT
DBV TECHNOLOGIE...
|
Healthcare | 0.41% | 0.39% |
#49
4
Prev: #53
|
3.2 |
—
|
688,959 | 71.4% |
P
S
|
1,653,350 | $27,114,940 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IRTC
IRHYTHM HOLDING...
|
Healthcare | 0.40% | 0.24% |
#50
12
Prev: #62
|
3.2 |
—
|
118,740 | 113.1% |
P
S
|
223,766 | $26,616,966 | 2016 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-50 of 123 holdings